Drug intelligence / Profile preview

Testagen

Development stage
Unknown
Lead developer
Transdermal Delivery Solutions
Modality
Small Molecules
Administration
Transdermal, Topical
01

Overview

Testagen is a transdermal testosterone replacement therapy developed by Transdermal Delivery Solutions Corp. It utilize a proprietary delivery system known as HypoSpray®, which is a metered-dose, quick-drying transdermal solution designed to deliver testosterone efficiently through the skin. This formulation is intended to treat male hypogonadism by providing stable serum androgen levels while specifically addressing the safety concern of inadvertent skin-to-skin transfer of testosterone to others (such as women and children), a common issue with traditional topical testosterone gels. The product is formulated as a 5% testosterone lotion or spray and has been evaluated in Phase II clinical trials to assess its pharmacokinetics and safety profile regarding accidental contact transfer.

Brand names
Testagen
Other names
Testagen TDS-TestosteroneTestagen TDS Testosterone 5% HypoSprayTestagen® TDS Testosterone 5% HypoSpray®
02

Targets

PepT1/PepT2 (Peptide transporters 1/2)LAT2 (Linker for activation of T cells family member 2)SLC7A5 (Large neutral amino acid transporter small subunit 1)H3 (Histone H3.2)DNA

Beyond the preview

Go deeper on Testagen.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Testagen.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call